My NCBISign In

Display Settings:

Format
Sort by

Send to:

Choose Destination

    Results: 4

    1.

    Ocrelizumab in relapsing-remitting multiple sclerosis: a phase 2, randomised, placebo-controlled, multicentre trial.

    Kappos L, Li D, Calabresi PA, O'Connor P, Bar-Or A, Barkhof F, Yin M, Leppert D, Glanzman R, Tinbergen J, Hauser SL.

    Lancet. 2011 Nov 19;378(9805):1779-87. Epub 2011 Oct 31.

    PMID:
    22047971
    [PubMed - indexed for MEDLINE]

    Related citations

    2.

    Multiple sclerosis-quenching the flames of inflammation.

    Chataway J, Miller DH.

    Lancet. 2011 Nov 19;378(9805):1759-60. Epub 2011 Oct 31. No abstract available.

    PMID:
    22047970
    [PubMed - indexed for MEDLINE]

    Related citations

    3.

    Hiccups, nausea, and vomiting: water channels under attack!

    Riphagen J, Modderman P, Verrips A.

    Lancet. 2010 Mar 13;375(9718):954. No abstract available.

    PMID:
    20226992
    [PubMed - indexed for MEDLINE]

    Related citations

    4.

    Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines.

    Black S, Eskola J, Siegrist CA, Halsey N, Macdonald N, Law B, Miller E, Andrews N, Stowe J, Salmon D, Vannice K, Izurieta HS, Akhtar A, Gold M, Oselka G, Zuber P, Pfeifer D, Vellozzi C.

    Lancet. 2009 Dec 19;374(9707):2115-22. Epub 2009 Oct 31. Erratum in: Lancet. 2010 Jan 30;375(9712):376.

    PMID:
    19880172
    [PubMed - indexed for MEDLINE]
    Free PMC Article

    Related citations

      Display Settings:

      Format
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Filters: Manage Filters

      Find related data

      Recent activity

      Clear Turn Off Turn On

      Your browsing activity is empty.

      Activity recording is turned off.

      Turn recording back on

      See more...
      You are here: NCBI > Literature > PubMed
      Write to the Help Desk